Winner Profile
Zhanguo Weng
CEO, formerly at Shanxi C&Y Pharmaceutical Group
Industry: Pharmaceuticals
Company size: Small
Published: 2015-10-13
Is Shanxi C&Y Pharmaceutical Group a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Zhanguo Weng (for his work at Shanxi C&Y Pharmaceutical Group) earned the following Obermatt pins for the management performance.
Obermatt accolades Zhanguo Weng
| Year | Pin | Category |
|---|---|---|
| 2015 |  |
Investment Performance |
 |
Growth Performance | |
|
Combined Performance | |
|
Operating Performance |
Zhanguo Weng is not included in a current Obermatt competition.
Performance Overview Zhanguo Weng
In summary, Zhanguo Weng obtained the following performances in the individual Obermatt categories over one participation in the Obermatt rankings (averages of all evaluated rankings are shown):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 79 in Combined Performance indicates that Zhanguo Weng was better than 79% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for one participation in Obermatt CEO competitions. Zhanguo Weng’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.